0001123292-18-000972.txt : 20180924
0001123292-18-000972.hdr.sgml : 20180924
20180924163248
ACCESSION NUMBER: 0001123292-18-000972
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180901
FILED AS OF DATE: 20180924
DATE AS OF CHANGE: 20180924
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bertolino Arthur Peter
CENTRAL INDEX KEY: 0001426344
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37357
FILM NUMBER: 181083864
MAIL ADDRESS:
STREET 1: C/O INNOVATION PHARMACEUTICALS INC.
STREET 2: 100 CUMMINGS CENTER, SUITE 151-B
CITY: BEVERLY
STATE: MA
ZIP: 01915
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Innovation Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001355250
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 134303398
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 100 CUMMING CENTER
STREET 2: SUITE 151-B
CITY: BEVERLY
STATE: MA
ZIP: 01915
BUSINESS PHONE: 978-921-4125
MAIL ADDRESS:
STREET 1: 100 CUMMING CENTER
STREET 2: SUITE 151-B
CITY: BEVERLY
STATE: MA
ZIP: 01915
FORMER COMPANY:
FORMER CONFORMED NAME: Cellceutix CORP
DATE OF NAME CHANGE: 20080515
FORMER COMPANY:
FORMER CONFORMED NAME: EconoShare, Inc.
DATE OF NAME CHANGE: 20060306
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2018-09-01
0001355250
Innovation Pharmaceuticals Inc.
IPIX
0001426344
Bertolino Arthur Peter
C/O INNOVATION PHARMACEUTICALS INC.
100 CUMMINGS CENTER, SUITE 151-B
BEVERLY
MA
01915
0
1
0
0
President and CMO
Class A Common Stock
2018-09-01
4
A
0
1066667
0
A
2699873
D
Employee Stock Option (right to buy)
.398
2018-09-01
4
A
0
617839
0
A
2028-09-01
Class A Common Stock
617839
617839
D
The restricted stock and stock options vest upon the earliest of (i) 50% on September 1, 2019 and 50% on September 1, 2020; (ii) the Company's common stock closes above $3.00 per share (as may be adjusted for any stock splits or similar actions); (iii) the commencement of trading of the Company's common stock on a national securities exchange; or (iv) upon a change of control of the Company, as defined in the Company's 2016 Equity Incentive Plan.
/s/ Arthur P. Bertolino
2018-09-24